Found 617 matching trials
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics
N/AInternational Observational Registry on Schizophrenia...
Location
Multiple Locations
Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
PHASE2The aim of this study is to explore potential for reduction of incidence an...
Location
Hospital General de Agudos Dr. Ignacio Pirovano
Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection
PHASE1This is a two-part, phase I/IIa study, intended to evaluate the safety, tol...
Location
Columbia University Medical Center
Trial to Compare Two Strains of BCG
PHASE4The trial will be a two-year outcome assessor-blinded RCT at the maternity ...
Location
Bandim Health Project
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
PHASE4Bacillus Calmette-Guérin (BCG) vaccination is recommended at birth to prote...
Status
Active Not Recruiting
Location
Bandim Health Project
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
PHASE2The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Location
The Queen Elizabeth Hospital
A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults
PHASE1The purpose of this study is to evaluate the safety and immunogenicity of t...
Location
GSK Investigational Site
Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults
PHASE1The purpose of the study is to evaluate the safety, tolerability, and immun...
Location
Brigham and Women's Hospital
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
PHASE1The purpose of this study is to determine the safety and efficacy of a PEPI...
Location
Duke University Medical Center
Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
PHASE1This study will evaluate the safety and immunogenicity of a tetravalent den...
Location
Center for Immunization Research, Johns Hopkins School of Public Health